GCP
BKYI

GSA Capital Partners’s BIO-key International BKYI Stock Holding History

GSA Capital Partners’s Portfolio BKYI Stock Details BKYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,331
Closed -$11K – 1664
2025
Q2 		$11K Buy
+1,331
New +$10.5K ﹤0.01% 1695

Other funds holding BKYI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

GSA Capital Partners's BKYI Position: Q3 2025 in Review

GSA Capital Partners sold out of BIO-key International (BKYI) in Q3 2025, closing a stake of 1,331 shares — an estimated $11K sold.

GSA Capital Partners first reported a position in BKYI in Q2 2025 and held it in 1 quarter. The position peaked at $11K in Q2 2025. 10 funds tracked by Wall St. Rank hold BKYI as of Q3 2025.

  • GSA Capital Partners reported no remaining BIO-key International position as of Q3 2025 after selling out during the quarter.
  • GSA Capital Partners sold 1,331 BIO-key International shares in Q3 2025, an estimated $11K.
  • GSA Capital Partners first reported a position in BIO-key International in Q2 2025 and held it in 1 quarter.
  • GSA Capital Partners's BIO-key International position peaked at $11K in Q2 2025.
  • 10 funds tracked by Wall St. Rank held BIO-key International as of Q3 2025.

Based on GSA Capital Partners's 13F filing for Q3 2025, filed 7 Nov 2025.